Serdemetan (JNJ-26854165)
Serdemetan (JNJ-26854165) acts as a HDM2 ubiquitin ligase antagonist and also induces early apoptosis in p53 wild-type cells, inhibits cellular proliferation followed by delayed apoptosis in the absence of functional p53. Phase 1.
Supplier | Selleck Chemicals |
---|---|
Product # | S1172 |
Sku # | S1172-25mg |
Pricing | 25mg, $370.00 |